8-K 1 form8kbody.txt 8K FILING RE: TERMINATION OF CEO SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 13, 2003 BOSTON BIOMEDICA, INC. ---------------------------------------------------- (Exact Name Of Registrant As Specified In Its Charter) MASSACHUSETTS -------------------------------------------- (State or Other Jurisdiction of Incorporation) 0-21615 04-2652826 ---------------------- --------------------------------- (Commission File Number) (I.R.S.Employer Identification No.) 375 West Street, West Bridgewater, MA 02379 -------------------------------------- -------- (Address of Principal Executive Offices) (Zip Code) (508) 580-1900 -------------------------------------------------- (Registrant's Telephone Number, Including Area Code) N/A ----------------------------------------------------------- (Former Name or Former Address, if Changed Since Last Report) ITEM 5. OTHER EVENTS ------ On February 14, 2003, Boston Biomedica, Inc. announced that the Company's Board of Directors had terminated Richard T. Schumacher as Chairman and Chief Executive Officer. A copy of the press release issued on February 14, 2003 regarding the termination of Mr. Schumacher is filed as Exhibit 99.1. ITEM 7. EXHIBITS ------ Exhibit Number Description -------------- ----------- 99.1 Press Release dated February 14, 2003 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: February 24, 2003 BOSTON BIOMEDICA, INC. By: /s/ Kevin W. Quinlan -------------------------------------- Kevin W. Quinlan, President and Chief Operating Officer and Treasurer INDEX TO EXHIBITS Exhibit Number Description ----------- ------------------------------------------------------ 99.1 Press Release dated February 14, 2003